The success of GLP-1 drugs underscores the value of sustained investment in basic research and the importance of exploring unconventional scientific pathways to drive breakthrough therapies.[123] The Weight Is Over: Increasing Demand for Anti-Obesity Medications Scientific advances and rising public health urgency have converged to drive substantial investment in GLP-1 therapies
It has been reported to cause vomiting, diarrhea, a fishy body odor, abdominal cramps, and nausea
Key benefits include: Blocking zonulin, a protein associated with increased intestinal permeability in conditions like celiac disease and leaky gut syndrome
191214, Pham-Huy, Lien Ai, et al
This makes HSA an ideal vehicle for ongoing GLP-1 therapy, which many patients continue for 12 months or longer
Oral glutathione has limited intestinal absorptiontypically 515%meaning much of the dose may not reach systemic circulation